<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_CN9rWNt">Economic Evaluations of Digital Health Interventions for the Management of Musculoskeletal Disorders: Systematic Review and Meta-Analysis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>PhD</roleName><forename type="first">Francis</forename><surname>Fatoye</surname></persName>
							<email>f.fatoye@mmu.ac.uk</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Health Professions , Manchester Metropolitan University , Manchester , United Kingdom</note>
								<orgName type="department">Department of Health Professions</orgName>
								<orgName type="institution">Manchester Metropolitan University</orgName>
								<address>
									<settlement>Manchester</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Lifestyle Diseases Research Entity , North West University , Potchefstroom , South Africa</note>
								<orgName type="department">Lifestyle Diseases Research Entity</orgName>
								<orgName type="institution">North West University</orgName>
								<address>
									<settlement>Potchefstroom</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Lifestyle Diseases Research Entity , North West University , Potchefstroom , South Africa</note>
								<orgName type="department">Lifestyle Diseases Research Entity</orgName>
								<orgName type="institution">North West University</orgName>
								<address>
									<settlement>Potchefstroom</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Tadesse</forename><surname>Gebrye</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Health Professions , Manchester Metropolitan University , Manchester , United Kingdom</note>
								<orgName type="department">Department of Health Professions</orgName>
								<orgName type="institution">Manchester Metropolitan University</orgName>
								<address>
									<settlement>Manchester</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MSc, MPH</roleName><forename type="first">Chidozie</forename><surname>Mbada</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Health Professions , Manchester Metropolitan University , Manchester , United Kingdom</note>
								<orgName type="department">Department of Health Professions</orgName>
								<orgName type="institution">Manchester Metropolitan University</orgName>
								<address>
									<settlement>Manchester</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Department of Health Professions Manchester Metropolitan University Birley Fields Campus Bonsall Street Manchester , M156GX United Kingdom</note>
								<orgName type="department">Department of Health Professions</orgName>
								<orgName type="institution">Manchester Metropolitan University</orgName>
								<address>
									<addrLine>Birley Fields Campus Bonsall Street</addrLine>
									<postCode>M156GX</postCode>
									<settlement>Manchester</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_duEbY2e">Economic Evaluations of Digital Health Interventions for the Management of Musculoskeletal Disorders: Systematic Review and Meta-Analysis</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">0596DCB76805102E7E3F70E5B7DF38B7</idno>
					<idno type="DOI">10.2196/41113</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T08:45+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_q4y3Ny9">musculoskeletal disorders</term>
					<term xml:id="_vbKAA9S">digital health interventions</term>
					<term xml:id="_TsrhzeZ">cost-effectiveness</term>
					<term xml:id="_mNbC8RN">systematic review</term>
					<term xml:id="_nG6HW77">digital health</term>
					<term xml:id="_EKBr3RD">intervention</term>
					<term xml:id="_9JnXNYG">management</term>
					<term xml:id="_Mfe3g57">musculoskeletal</term>
					<term xml:id="_5eBADAQ">muscles</term>
					<term xml:id="_b6px9uv">joints</term>
					<term xml:id="_DZQDmXD">nerves</term>
					<term xml:id="_aj3VZ9W">blood</term>
					<term xml:id="_J6r48np">pain</term>
					<term xml:id="_X75uMvH">knee</term>
					<term xml:id="_Cj8q7P3">hip</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_azAMStg"><p xml:id="_vGaJywz"><s xml:id="_yh4aXuu">Background: Musculoskeletal disorders (MSDs) are widespread in many countries and their huge burden on the society has necessitated innovative approaches such as digital health interventions.</s><s xml:id="_qC4E3mM">However, no study has evaluated the findings of cost-effectiveness of these interventions.</s></p><p xml:id="_jXcTF93"><s xml:id="_92zwc8b">Objective: This study aims to synthesize the cost-effectiveness of digital health interventions for people with MSDs.</s></p><p xml:id="_VzjnYAG"><s xml:id="_VC9Xzn6">Methods: Electronic databases including MEDLINE, AMED, CIHAHL, PsycINFO, Scopus, Web of Science, and Centre for Review and Dissemination were searched for cost-effectiveness of digital health published between inception and June 2022 following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.</s><s xml:id="_xVNkTa4">References of all retrieved articles were checked for relevant studies.</s><s xml:id="_h8hKatY">Quality appraisal of the included studies was performed using the Quality of Health Economic Studies (QHES) instrument.</s><s xml:id="_C4AjK6f">Results were presented using a narrative synthesis and random effects meta-analysis.</s></p><p xml:id="_MjnvwGu"><s xml:id="_QXsVMrn">Results: A total of 10 studies from 6 countries met the inclusion criteria.</s><s xml:id="_JF9MFKk">Using the QHES instrument, we found that the mean score of the overall quality of the included studies was 82.5.</s><s xml:id="_SmkcFFB">Included studies were on nonspecific chronic low back pain (n=4), chronic pain (n=2), knee and hip osteoarthritis (n=3), and fibromyalgia (n=1).</s><s xml:id="_Z4fYQks">The economic perspectives adopted in the included studies were societal (n=4), societal and health care (n=3), and health care (n=3).</s><s xml:id="_4JXfAKn">Of the 10 included studies, 5 (50%) used quality-adjusted life-years as the outcome measures.</s><s xml:id="_KBhGX8W">Except 1 study, all the included studies reported that digital health interventions were cost-effective compared with the control group.</s><s xml:id="_MqpKFYc">In a random effects meta-analysis (n=2), the pooled disability and quality-adjusted life-years were -0.176 (95% CI -0.317 to -0.035; P=.01) and 3.855 (95% CI 2.023 to 5.687; P&lt;.001), respectively.</s><s xml:id="_T5ayTa4">The meta-analysis (n=2) for the costs was in favor of the digital health intervention compared with control: US $417.52 (95% CI -522.01 to -313.03).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KETMAN5">Conclusions:</head><p xml:id="_FAahstD"><s xml:id="_ESYHEmr">Studies indicate that digital health interventions are cost-effective for people with MSDs.</s><s xml:id="_7nYZ8mA">Our findings suggest that digital health intervention could help improve access to treatment for patients with MSDs and as a result improve their health outcomes.</s><s xml:id="_B9u8kKb">Clinicians and policy makers should consider the use of these interventions for patients with MSDs.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mnQuR3H">Introduction</head><p xml:id="_Wje8yk8"><s xml:id="_7NhDA9P">Musculoskeletal disorders (MSDs), which comprise a wide range of inflammatory and degenerative conditions affecting the muscles, ligaments, joints, tendons, peripheral nerves, and supporting blood vessels, are widespread in many countries <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_EeaGC5z">The burden of MSDs is substantial and increasing globally, particularly in the most economically deprived countries <ref type="bibr" target="#b1">[2]</ref>.</s><s xml:id="_NCmTjA5">According to The Global Burden of Disease Study 2017 <ref type="bibr" target="#b2">[3]</ref>, the point prevalence and associated death rates of MSDs were 4151.1 and 1.0 per 100,000 population, respectively.</s><s xml:id="_eNeFqwW">According to Safiri et al <ref type="bibr" target="#b2">[3]</ref>, the prevalence estimate of MSDs was higher among females and increased with age; further, MSDs led to about 30.8 million disability-adjusted life-years worldwide, which is an increase of 3.4% from 1990 to 2017.</s><s xml:id="_33KrZRF">Low back pain (LBP) is the main contributor to the overall burden of MSDs, but other contributors are rheumatoid arthritis (14 million), amputations (175 million), neck pain (222 million), osteoarthritis (343 million), and fractures (436 million) <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_es4Nyc2">The cost of managing MSDs in the United States was estimated to be US $213 billion in direct and indirect costs, that is, 1.4% of the US gross domestic product, in 2011 <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_Zx3TrMd">It also cost the United Kingdom economy £10.2 billion (US $12.62 billion) in direct costs to the National Health System in 2017 <ref type="bibr" target="#b5">[6]</ref>.</s></p><p xml:id="_NDRZH57"><s xml:id="_79uNsPb">In response to the growing burden of MSDs, the World Health Organization launched "the Rehabilitation 2030 Initiative" in 2017 <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_ZR68Ban">This initiative draws attention to the importance of strengthening health system to provide rehabilitation, which is defined as a set of intervention designed to optimize functioning and reduce disability in individuals with health conditions in interaction with their environment.</s><s xml:id="_kFFJXPt">One of the innovative approaches to deliver rehabilitation to patients with MSDs is through the use of digital technologies.</s><s xml:id="_JGDjXra">Digital health interventions may help overcome barriers to both delivering health care and care for chronic conditions <ref type="bibr" target="#b7">[8]</ref>.</s><s xml:id="_8qjGckk">Digital health interventions may include any intervention accessed through a computer, a smartphone, or any other hand-held device.</s><s xml:id="_7D6CsjW">Thus, digital health interventions have the advantage of being user flexible, where patients could receive care remotely without having to travel <ref type="bibr" target="#b8">[9]</ref>.</s></p><p xml:id="_X5vYAWy"><s xml:id="_DjrsWas">Compared with traditional models of care, digital health interventions are reported to have added benefits in providing evidence-based first-line care, low cost, and scalable patient education delivered via apps or web platform across a wide range of conditions <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref>.</s><s xml:id="_ge5GjfZ">Digital health intervention has also demonstrated its clinical benefit in the management of patients with MSDs <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_qqaYPyv">To identify the most effective intervention with the least expenses, it is necessary to compare the costs and effectiveness of various digital health interventions.</s><s xml:id="_2QkQ5GE">Apparently, there are no reviews that appraise individual studies and summarize results of the cost-effectiveness of digital health interventions on patients with MSDs.</s><s xml:id="_Dvxywbr">Therefore, this study was aimed to analyze evidence to identify whether digital health interventions are a cost-effective option for patients with MSDs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Wtutkg8">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9tSASAJ">Search Protocol and Registration</head><p xml:id="_PvQM9v7"><s xml:id="_h9yx4fa">In this study, we used the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guideline (Multimedia Appendix 1), an evidence-based approach developed by Liberati in 2009 <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_4Br9RtF">The systematic review protocol was also registered on PROSPERO (CRD42021253221).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_zZGAqDU">Search Strategy</head><p xml:id="_nSnzmkW"><s xml:id="_gVJrzrH">We performed a systematic search of the following electronic databases to identify studies evaluating the cost-effectiveness of digital health interventions: MEDLINE, AMED, CIHAHL, PsycINFO, Scopus, Web of Science, and Centre for Review and Dissemination.</s><s xml:id="_zEkRAM6">The search was conducted from inception to June 2022.</s><s xml:id="_fmtZqU4">The included search terms are listed in Multimedia Appendix 2. Further, a manual search of reference sections of the included studies was performed to identify additional studies.</s><s xml:id="_3pQAbx4">The search was delimited to articles published in English.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pFSU8tS">Inclusion and Exclusion Criteria</head><p xml:id="_RzPdcVa"><s xml:id="_9qqDsWb">The inclusion criteria were economic evaluations (cost-effectiveness, cost-utility, cost-consequence, and cost-benefit analysis) performed in an adult population (aged &gt;18 years) with musculoskeletal conditions; any form of digital health intervention delivered through an app or internet, with the comparators being no intervention, standard care, or any other nondigital forms of health interventions, was considered.</s><s xml:id="_655NgXw">We defined digital health interventions to include targeted client communication; personal health tracking; and on-demand information services delivered by apps, web-based software, or websites.</s><s xml:id="_JMrmvcE">The incremental cost-utility ratio (ICUR; ie, cost per quality-adjusted life-year [QALY]) and incremental cost-effectiveness ratio (ICER; ie, clinically relevant outcome such as pain intensity, disability, global perceived effect/recovery) were outcomes of the studies.</s><s xml:id="_MChqpYt">The exclusion criteria were nonmusculoskeletal pathology, nondigital health interventions, study protocols, case studies/discussion papers, pilot studies, conference abstracts, and studies where the ICER was not calculated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QY3KPdY">Study Selection and Assessment of Methodological Quality</head><p xml:id="_ueq2B4w"><s xml:id="_Bg5V63X">Following the removal of duplicates, titles and abstracts were screened by 2 reviewers (TG and FF) independently to identify eligible studies.</s><s xml:id="_CsxVQzt">The full texts of the identified studies were checked against the inclusion and exclusion criteria.</s><s xml:id="_2gDvn4f">The quality of the included studies was assessed and graded using the Quality of Health Economic Studies (QHES) instrument <ref type="bibr" target="#b13">[14]</ref>.</s><s xml:id="_HVeV2Nh">The QHES instrument consists of 16 items with scores ranging from 1 to 9, and the total score of the instrument is 100.</s><s xml:id="_sajxn6C">During the assessment process, if the included study satisfied the criterion of an item, the study received an item-specific score; otherwise it received a score of 0. Each question has a weighted point value ranging from 1 to 9, which is used to generate a summary score from 0 to 100.</s><s xml:id="_h32ru4S">As no standardized interpretation of the QHES exists, we adopted the score of 75-90 as good quality and a score of 90 and above as excellent quality, as applied by Tran and colleagues <ref type="bibr" target="#b14">[15]</ref>.</s><s xml:id="_5WUfSu3">Two reviewers (TG and FF) participated in the study selection and methodological quality assessment.</s><s xml:id="_63sfr8V">Any disagreement was resolved by discussion and consensus with the third reviewer (CM).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_UFenzvG">Data Extraction</head><p xml:id="_KR2RH6m"><s xml:id="_gkBs53f">The following data were extracted by 2 reviewers (TG and FF): general information (author, year, and country), characteristics of participants (age, sample size, and disease type), description of intervention (duration of follow-up, intervention modalities [intensity and frequency], and comparator), economic evaluation (perspective, currency, types, cost/willingness to pay [WTP], and reference year), and study results (including clinical outcomes, costs, differences in clinical and costs outcomes, and ICER/ICUR).</s><s xml:id="_BY5ngvp">A summary table was used to display the extracted data.</s><s xml:id="_Tug5tRf">Disagreements were addressed through consultation with the third reviewer (CM).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QYA4m47">Data Analysis</head><p xml:id="_GNcBa6S"><s xml:id="_gAqYAWY">The descriptive characteristics, quality of the included studies, and ICER/ICUR were descriptively analyzed.</s><s xml:id="_AE58wtK">The quantitative results were carefully assessed for their suitability for meta-analysis.</s><s xml:id="_4UcVpyQ">The included studies were grouped according to the disease type, time of follow-up, and clinical outcome measures.</s><s xml:id="_PhMFxRT">The mean costs and effects differences were then combined in a meta-analysis.</s><s xml:id="_VUwCex2">A random effects meta-analysis model was used to pool the results from the individual studies.</s><s xml:id="_TwmRwNH">Because of the statistical evidence of heterogeneity across the included studies, a random effects model was chosen <ref type="bibr" target="#b15">[16]</ref>.</s><s xml:id="_5dXkryW">The assessment of heterogeneity was based on the I 2 statistic.</s><s xml:id="_rkK9ZXU">If substantial heterogeneity was present (ie, I 2 &gt;50%), we tried to find an explanation for this heterogeneity.</s></p><p xml:id="_S8fUBHu"><s xml:id="_gwMWyYR">All costs were converted to US dollars using purchasing power parities <ref type="bibr" target="#b16">[17]</ref>.</s><s xml:id="_4U83TBE">We adjusted the cost data to the reference year (2021) using the consumer price index from the World Bank website <ref type="bibr">[18]</ref>.</s><s xml:id="_9gB3rwm">The intervention was considered cost-effective and not cost-effective when it was more effective and less costly and less effective and more costly compared with a comparator treatment, respectively <ref type="bibr" target="#b17">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Z6PzJMc">Ethical Approval</head><p xml:id="_c82HF3H"><s xml:id="_WN4JcJv">For this study ethical approval is not required.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7bxUR6E">Informed Consent</head><p xml:id="_wJUZUfF"><s xml:id="_PasFCR6">The patient's written informed consent was not made, as this was a systematic review study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TCFkREz">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6GU5MMD">Study Selection</head><p xml:id="_fvjQxPk"><s xml:id="_sJp8FrG">We identified 1386 records in Scopus (n=1076); Web of Science (n=235); Centre for Review and Dissemination/NHS Economic Evaluation Database (n=13); and MEDLINE, AMED, CINAHL, PsycINFO (n=62; Figure <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_kDAFqT4">Of these records, 343 were duplicates.</s><s xml:id="_Y3YrsNa">Following screening by titles and abstracts, 986 studies were excluded, leaving 57 articles for full-text review.</s><s xml:id="_jJFPeXW">After reading the full text of these articles, only 10 met the inclusion criteria and were eligible for this systematic review and meta-analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_UWZuHZZ">Quality of the Included Studies</head><p xml:id="_aE4uVXm"><s xml:id="_kB7En9S">The average QHES score for the included studies was 82.5.</s><s xml:id="_8KagyV3">The detailed results of the quality assessment are shown in Table <ref type="table">1</ref>.</s></p><p xml:id="_FXXQ6r8"><s xml:id="_TkjqDgb">Most of the included studies were conducted reasonably with good quality.</s><s xml:id="_3BWtPBa">However, many studies have failed to deal with subgroup analysis, discussion of potential bias, and use of best available sources.</s></p><p xml:id="_AUVkn3S"><s xml:id="_xcjTWJc">Table 1.</s><s xml:id="_5xXceG2">Quality assessment for the included studies.</s></p><p xml:id="_JmACfSS"><s xml:id="_PKpaMvw">de Boer et al <ref type="bibr" target="#b27">[29]</ref> Weinberger et al <ref type="bibr" target="#b26">[28]</ref> O'Brien et al <ref type="bibr" target="#b25">[27]</ref> Hedman-Lagerlöf et al <ref type="bibr" target="#b24">[26]</ref> Williams et al <ref type="bibr" target="#b23">[25]</ref> Paganini et al <ref type="bibr" target="#b22">[24]</ref> Fatoye et al <ref type="bibr" target="#b21">[23]</ref> Zachwieja et al <ref type="bibr" target="#b20">[22]</ref> Dear et al <ref type="bibr" target="#b19">[21]</ref> Suman et al <ref type="bibr" target="#b18">[20]</ref> Items</s></p><formula xml:id="formula_0">1 1 1 1 1 1 1 1 1 1 a</formula><p xml:id="_nmRSjSu"><s xml:id="_ZRNzDPE">Was the study objective presented in a clear, specific, and measurable manner?</s></p><formula xml:id="formula_1">0 1 1 1 1 1 1 0 c 1 0.5 b</formula><p xml:id="_eANQ3je"><s xml:id="_hed7uHq">Were the perspectives of the analysis (eg, societal, third-party payer) and reasons for its selection stated?</s></p><formula xml:id="formula_2">1 1 1 1 1 1 1 0 1 1</formula><p xml:id="_9FsYTzB"><s xml:id="_tcfH9ff">Were variable estimates used in the analysis from the best available source (ie, randomized control trial-best, expert opinion-worst)?</s><s xml:id="_mPEDVW3">0 0 0 0 0 0 0 1 0 0 If estimates came from a subgroup analysis, were the groups prespecified at the beginning of the study?</s></p><formula xml:id="formula_3">0 0 1 1 1 1 0 0 1 1</formula><p xml:id="_p262avt"><s xml:id="_SykmR8s">Was uncertainty handled by (1) statistical analysis to address random events and (2) sensitivity analysis to cover a range of assumptions?</s></p><formula xml:id="formula_4">1 1 1 1 1 1 1 1 1 1</formula><p xml:id="_4jruwpf"><s xml:id="_dTXqcem">Was an incremental analysis performed between alternatives for resources and costs?</s></p><formula xml:id="formula_5">1 1 Y 1 1 1 1 1 1 1</formula><p xml:id="_NW26eAq"><s xml:id="_wDwnhdT">Was the methodology for data abstraction (including the value of health states and other benefits) stated?</s></p><formula xml:id="formula_6">1 1 1 1 1 1 1 1 1 1</formula><p xml:id="_AkDXS3R"><s xml:id="_EaTe4yE">Did the analytic horizon allow time for all relevant and important outcomes?</s><s xml:id="_z5BjAqe">Were benefits and costs that went beyond 1 year discounted (3%-5%) and justification given for the discount rate?</s></p><formula xml:id="formula_7">1 1 1 1 1 1 1 1 1 1</formula><p xml:id="_passTXF"><s xml:id="_73K7mWw">Was the measurement of costs appropriate and the methodology for the estimation of quantities and unit costs clearly described? 1 1 0 0 0 0 0 0 0 0 Was the primary outcome measure(s) for the economic evaluation clearly stated and was the major short-term justification given for the measures/scales used?</s></p><formula xml:id="formula_8">1 1 1 1 1 1 1 1 1 1</formula><p xml:id="_v67svN6"><s xml:id="_NYN8vRf">Were the health outcomes measures/scales valid and reliable?</s><s xml:id="_y8N2VfF">If previously tested valid and reliable measures were not available, was justification given for the measures/scales used?</s></p><formula xml:id="formula_9">1 0 1 1 1 1 1 0 1 1</formula><p xml:id="_KC4pGHP"><s xml:id="_b5BJERB">Were the economic model (including structure), study methods and analysis, and the components of the numerator and denominator displayed in a clear and transparent manner?</s></p><formula xml:id="formula_10">1 0.5 1 1 1 0.5 0.5 0.5 0.5 1</formula><p xml:id="_gST5mnf"><s xml:id="_kwewUtu">Were the choice of economic model, main assumptions, and limitations of the study stated and justified?</s></p><formula xml:id="formula_11">1 0 1 1 1 0 0 1 1 1</formula><p xml:id="_uhhVz3n"><s xml:id="_mMKr2dj">Did the author(s) explicitly discuss direction and magnitude of potential biases?</s></p><formula xml:id="formula_12">1 1 1 1 1 1 1 1 1 1</formula><p xml:id="_U6uhbcd"><s xml:id="_SU4fC8u">Were the conclusions/recommendations of the study justified and based on the study results?</s></p><formula xml:id="formula_13">1 0 1 1 1 1 1 0 1 1</formula><p xml:id="_5JQKaMB"><s xml:id="_ff4c25B">Was there a statement disclosing the source of funding for the study?</s><s xml:id="_grZs69V">a 1=yes.</s><s xml:id="_GaRNXmb">b 0.5=yes/no.</s><s xml:id="_FXrs5xG">c 0=no.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_x4DATg7">Characteristics of Included Studies</head><p xml:id="_vPx7J8Q"><s xml:id="_97NNNwJ">A total of 10 studies from 6 countries that met the inclusion criteria were included in this study (The Netherlands, n=2; Australia, n=3; Sweden, n=2; Nigeria, n=1; Germany, n=1; and United States of America, n=1; Table <ref type="table" target="#tab_1">2</ref>).</s><s xml:id="_W866XmT">These studies were published between 1993 and 2021.</s><s xml:id="_X693TUJ">The sample size used to estimate the cost-effectiveness of digital health intervention in the included studies ranged from 47 to 779.</s><s xml:id="_PGAP5Sr">The included studies were on LBP (n=4), chronic pain (n=3), and knee and hip osteoarthritis (n=3).</s><s xml:id="_KS4apps">The economic perspectives adopted in the included studies were societal (n=4), societal and health care (n=3), and health care (n=3); 5 of the included studies performed cost-effectiveness analysis, 2 studies performed cost-utility analysis, and the remaining performed both cost-effectiveness and cost-utility analysis.</s><s xml:id="_n3eyqDu">The time horizon of these studies ranged from 8 weeks to 1 year.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SbeFwVy">Cost-Effectiveness of Digital Health Interventions</head><p xml:id="_4YMgHsm"><s xml:id="_9mRvcDe">The results of the cost-effectiveness and cost-utility analyses of digital health intervention of the included studies are described in this section (also see Table <ref type="table">3</ref>).</s><s xml:id="_hSZaAat">Except 1 study <ref type="bibr" target="#b25">[27]</ref>, all the included studies reported that digital health interventions were cost-effective compared with the control group.</s><s xml:id="_AUPvd7g">All the included studies provided the ICER and ICUR indicating the dominance of the interventions.</s></p><p xml:id="_ExzgGhh"><s xml:id="_pN7Uhb5">Table <ref type="table">3</ref>. Clinical outcomes and incremental cost-effectiveness ratios of the included studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_G25dDkE">Incremental cost-effectiveness ratios Clinical outcomes Author, country</head><p xml:id="_mRvhtU8"><s xml:id="_B6EK3CR">Suman et al <ref type="bibr" target="#b18">[20]</ref>,</s></p><p xml:id="_eu3fJdR"><s xml:id="_XFVScaV">•</s></p><p xml:id="_tMzJH48"><s xml:id="_dx8mf6k">The incremental cost-effectiveness ratios indicated that the intervention dominated usual care and the probability of cost-effec-</s></p><p xml:id="_w9dhEfC"><s xml:id="_G8J8DCd">• Disability score: intervention group=mean 5.1 (SD 4.7); control group=mean 5.9 (SD 5.3) The tiveness was 0.85 on a willingness to pay of €10,000 a /quality-• Back pain beliefs score: intervention group=mean 24.7 (SD 6.0); control group=mean 24.8 (SD 6.2) Netherlands adjusted life-year.</s><s xml:id="_McgN5Nm">Dear et al [21], Australia • For a ≥30% reduction in disability, depression, anxiety, and pain, the costs were as follows: a self-guided format, Aus $404 b -Aus $808; an optional-guided format, Aus $314-Aus $541; and the • Disability (≥30% improvement): self-guided format=39% (95% CI 30 to 48); optional-guided format=40% (95% CI 32 to 48); clinician-guided format=42% (95% CI 34 to 51); and control group=9% (95% CI 2 to 17) clinician-guided format, Aus $88-Aus $225.</s><s xml:id="_PQgGuGu">• Pain intensity (≥30% improvement): control=8% (95% CI 1 to 15); self-guided format=23% (95% CI 15 to 31); optionalguided format=26% (95% CI 18 to 34); and clinician-guided format=21% (95% CI 14 to 28) Ekman et al [30], Sweden • Digital model costs around 25% of the existing face-to-face model of care.</s><s xml:id="_qxE73eE">Digital model and better management of patients with osteoarthritis report on average a reduction in experienced pain from 5.7 to 3.2 and 5.2 to 4.1 after 12 weeks, respectively.</s></p><formula xml:id="formula_14">• N/A c</formula><p xml:id="_CRp6gSB"><s xml:id="_etMeBqW">• The incremental cost-effectiveness ratio was 8705 SEK d /effect improvement.</s></p><p xml:id="_uNdrQXR"><s xml:id="_Eb8fsxQ">Fatoye et al <ref type="bibr" target="#b21">[23]</ref>, Nigeria</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gnBzsHZ">•</head><p xml:id="_jVEhfqV"><s xml:id="_4XXvHus">The telerehabilitation was associated with an additional 0.001 quality-adjusted life-years (95% CI 0.001 to 0.002) per participant compared with the clinic-based arm.</s></p><p xml:id="_yy9QUN9"><s xml:id="_aycApRk">• Quality-adjusted life-years: intervention group=0.085</s><s xml:id="_y5MEmwX">(95% CI 0.80 to 0.09); control group=0.084</s><s xml:id="_TBTvq6C">(95% CI 0.084 to 0.085) • Disability: intervention group=15.71</s><s xml:id="_9vWt6Yv">(95% CI 12.85 to 18.57); control group=14.50</s><s xml:id="_DuVN4R8">(10.63-18.36)</s><s xml:id="_YvMe9mJ">Paganini et al [24], Germany • Treatment response and quality-adjusted life-years were highest in the ACTonPain guided group (44% and 0.280; mean costs=€6945), followed by the ACTonPain unguided group (28% • Quality-adjusted life-years (AQoL-8D e ): ACTonPain guid- ed f =mean 0.44 (SD 0.05); ACTonPain unguided =mean 0.266 (SD 0.09); and waitlist control group=mean 0.244 (SD 0.08) and 0.266; mean costs=€6560) and the control group (16% and • Treatment response (pain interference): ACTonPain guid- 0.244; mean costs=€6908).</s><s xml:id="_rWE7em9">The ACTonPain guided group versus ed =mean 0.44 (SD 0.05); ACTonPain unguided =mean 0.277 the control group revealed an incremental cost-effectiveness ratio (SD 0.04); and waitlist control group=mean 0.158 (SD 0.04) of €45 and an incremental cost-utility ratio of €604.</s><s xml:id="_VjWnasy">The ACTon-Pain unguided group dominated the control group.</s><s xml:id="_UXbDvVE">Williams et al [25], Australia • Societal: mean total costs were lower in the intervention group than in the control group (US $614; 95% CI -3133 to 255).</s><s xml:id="_FFKDHaF">• N/A • Health care: mean total costs were higher in the intervention group than in the control group (US $386; 95% CI -188 to 688).</s><s xml:id="_aVVuWUx">• No differences were found between the intervention and control groups in quality-adjusted life-years (mean difference 0.02; 95% CI -0.00 to 0.04), pain (mean difference -0.35; 95% CI -1.33 to 0.64), disability (mean difference -0.57; 95% CI -10.41 to 9.27), weight (mean difference -2.04; 95% CI -4.22 to 0.14), and BMI (mean difference -0.67; 95% CI -1.44 to 0.09).</s><s xml:id="_SRKHAbH">• For all outcomes, the intervention was on average less expensive and more effective than usual care, and the probability of the intervention being cost-effective compared with usual care was relatively high (ie, 0.81) at a willingness to pay of US $0/unit of effect.</s><s xml:id="_rMDHXbD">Hedman-Lagerlöf • Intervention group, mean 36.44 (SD 25.56); control group, mean 57.71 (SD 21.62) • EuroQol five-dimensional: intervention group=mean 0.60 (SD 0.30); control group=mean 0.44 (SD 0.32) et al [26], Sweden • • Fibromyalgia Impact Questionnaire: intervention group=mean 36.44 (SD 25.56); control group=mean 57.51 (SD 21.62)</s></p><p xml:id="_WjVGT9P"><s xml:id="_A46qneM">The mean score on the Fibromyalgia Impact Questionnaire for the experimental group at the 12-month follow-up was 39.95 (SD 21.77), representing a nonsignificant change.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ADs3yGa">•</head><p xml:id="_ceWcvNf"><s xml:id="_nUYxCG6">The incremental cost-effectiveness ratio was -5025/0.33=-US</s><s xml:id="_ZpCCGay">$15,295.</s><s xml:id="_qMGZUmA">This means that for 1 additional responder to treatment, there was a societal cost saving of US $15,295.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Q94D45X">•</head><p xml:id="_2mVs9QA"><s xml:id="_DUArT5Q">Taking a health care unit perspective, the corresponding incremental cost-effectiveness ratio was 726/.33, which equates to around US $2211.</s></p><p xml:id="_yfUTuBC"><s xml:id="_vBgz42q">Incremental cost-effectiveness ratios Clinical outcomes Author, country</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_v4QZYaN">•</head><p xml:id="_3U65reT"><s xml:id="_PD9FjJE">Mean cost differences between groups (intervention minus control) were Aus $493 (95% CI -3513 to 5363) for health care costs, Aus $-32 (95% CI -73 to 13) for medication costs, and Aus $125 (95% CI -151 to 486) for absenteeism costs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qSWBhKV">•</head><p xml:id="_S7Jn8HS"><s xml:id="_vT2V5MK">The total mean difference in societal costs was Aus $1197 (95% CI -2887 to 6106).</s><s xml:id="_69YXH8g">For quality-adjusted life-years and all clinical measures of effect, the probability of the intervention being costeffective compared with usual care was less than 0.36 at all willingness-to-pay values.</s></p><p xml:id="_zGVMtdr"><s xml:id="_VyHH2WQ">• N/A O'Brien et al <ref type="bibr" target="#b25">[27]</ref>, Australia</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pBPS6FU">•</head><p xml:id="_HZmdAp9"><s xml:id="_FMRdfHG">The costs to achieve 1-unit improvements in physical functioning and pain (US $71.00 and US $31.00, respectively) over 1 year were extremely low.</s><s xml:id="_D3wRqU6">The annual costs for a 1-unit improvement in physical functioning and pain, as measured by the Arthritis Impact Measurement scale, were US $70.86 and US $31.00, respectively.</s></p><p xml:id="_G8Cun6a"><s xml:id="_mVyahgV">• N/A Weinberger et al <ref type="bibr" target="#b26">[28]</ref>, United States • Pain Catastrophizing Scale: intervention group, mean 11.00 (SD 11.49); control group, mean 16.10 (SD 11.56) • Visual Analog Scale-Pain: intervention group, mean 5.19 (SD 2.53); control group, mean 5.49 (SD 2.32) • RAND-36 Physical functioning: intervention group, mean 58.50 (SD 22.37); control group, mean 55.88 (SD 22.35) • Pain Catastrophizing Scale score: intervention group=mean 0.69; control group=mean 0.37 • Visual Analog Scale-Pain score: intervention group=mean 0.62; control group=mean 0.06 • RAND-36 Physical Functioning score: intervention group=mean 0.42; control group=mean 0.15 de Boer et al [29], The Netherlands a €1=US $1.08 (as of June 12, 2023).</s><s xml:id="_4KzTh53">b Aus $1=US $0.67 (as of June 12, 2023).</s><s xml:id="_ZEE8Kdq">c N/A: not available.</s><s xml:id="_nQnbYhT">d 1 SEK=US $0.09.</s><s xml:id="_RGEmhnQ">e AQoL-8D: Assessment of Quality of Life 8-Dimension.</s><s xml:id="_tpKTeBn">f ACT: acceptance and commitment therapy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JNMKqVU">Low Back Pain</head><p xml:id="_SFDTDJj"><s xml:id="_cP9hAJF">A total of 4 studies <ref type="bibr" target="#b18">[20,</ref><ref type="bibr" target="#b21">[23]</ref><ref type="bibr" target="#b22">[24]</ref><ref type="bibr" target="#b23">[25]</ref> reported the cost-effectiveness of digital health intervention on people with LBP.</s><s xml:id="_Z6Kk99Q">The digital health intervention consisted of an informative website, digital monthly newsletters, and social media platforms <ref type="bibr" target="#b18">[20]</ref>; telerehabilitation using a mobile phone-based app <ref type="bibr" target="#b21">[23]</ref>; internet-based intervention such as information, metaphors, assignments, and mindfulness exercises <ref type="bibr" target="#b22">[24]</ref>; as well as a brief telephone advice, a clinical consultation with a physiotherapist, and referral to a 6-month telephone-based health coaching service <ref type="bibr" target="#b23">[25]</ref>.</s><s xml:id="_fcZ9FNG">The clinical outcomes measured were back pain beliefs, disability, and health-related quality of life.</s></p><p xml:id="_BJpk3UR"><s xml:id="_mtumaUN">All these studies concluded that digital health interventions seem to be cost-effective from the health care and societal perspectives.</s><s xml:id="_9xwsP6V">The multifaceted eHealth intervention that aimed to reduce patients back pain, generated on average, a WTP of €10,000 (US $10,778.53)</s><s xml:id="_y4TWFTX">per QALY at a probability .85</s><s xml:id="_qYvtpPD">being cost-effective <ref type="bibr" target="#b18">[20]</ref>.</s><s xml:id="_PRMgbZj">Telerehabilitation was associated with an additional 0.001 QALY per participant compared with the control condition and the telerehabilitation was dominant <ref type="bibr" target="#b21">[23]</ref>.</s><s xml:id="_vxmsKPZ">The guided internet-based interventions' probability of being more cost-effective compared with the control condition increased up to 70% and to 95% at a WTP of €24,415 (US $26,315.78)</s><s xml:id="_WD7EbYp">and €91,000 (US $98,084.62),</s><s xml:id="_q8c3Gsn">respectively <ref type="bibr" target="#b22">[24]</ref>.</s><s xml:id="_v6nx6kM">For all clinical outcomes, an intervention involving a brief telephone advice, a clinical consultation with a physiotherapist, and referral to a 6-month telephone-based health coaching service was on average less expensive and more effective than usual care, and its probability of being cost-effective compared with usual care was relatively high (ie, 0.81) at a WTP of US $0/unit of effect <ref type="bibr" target="#b23">[25]</ref>.</s></p><p xml:id="_uN3bRAz"><s xml:id="_uQwfugh">A meta-analysis was conducted for disability, QALY, and cost (Figure <ref type="figure" target="#fig_1">2</ref>).</s><s xml:id="_FVysVEW">A statistically significant mean difference in disability (mean difference -0.176; 95% CI -0.317 to -0.035; P=.01) and QALY (mean difference 3.855; 95% CI 2.023 to 5.687; P&lt;.001) was identified.</s><s xml:id="_hPVGwYX">The meta-analysis for the costs of 2 studies <ref type="bibr" target="#b22">[24,</ref><ref type="bibr" target="#b23">25]</ref> favors the digital health intervention compared with the control condition (mean difference -US $0.339; 95% CI -0.610 to -0.187; P&lt;.001</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JsZqp9U">Osteoarthritis</head><p xml:id="_x9NAy8H"><s xml:id="_xKGh4EZ">Two studies <ref type="bibr" target="#b25">[27,</ref><ref type="bibr" target="#b26">28]</ref> documented the cost-effectiveness of digital health intervention on patients with osteoarthritis.</s><s xml:id="_Kk4RQQh">A digital, structured, and individualized treatment program and telephone-based health coaching service were the contents of the digital health interventions.</s><s xml:id="_pxxQ6DS">The included studies indicated that patients have improved their health-related quality of life, pain intensity, disability, and physical function due to the interventions.</s><s xml:id="_u3xt6CQ">Although 1 of the included studies <ref type="bibr" target="#b25">[27]</ref> reported that the digital intervention was not cost-effective, a study conducted in the United States <ref type="bibr" target="#b26">[28]</ref> indicated that it is potentially cost-effective in osteoarthritis.</s></p><p xml:id="_CJJddtf"><s xml:id="_en9MK4c">The digital, structured, and individualized treatment program reported on average a reduction in experienced pain from 5.7 to 3.2 (a reduction by 2.5 points on a 0-10 scale, or a 44% reduction) after 12 weeks <ref type="bibr" target="#b28">[30]</ref>.</s><s xml:id="_GtRN8HB">Based on the cost-effectiveness ratio, the intervention arm was associated with 8705 SEK (US $805.92) per effect improvement.</s><s xml:id="_4qccFKk">From the societal and health care perspectives, the mean cost difference between the telephone-based health coaching service and control were US $1197 (95% CI -2887 to 6106) and US $493 (95% CI -3513 to 5363), respectively <ref type="bibr" target="#b25">[27]</ref>.</s><s xml:id="_Ts7tYnr">For QALYs and all clinical measures of effect, the probability of the telephone-based health coaching service being cost-effective compared with usual care was less than 0.36 at all WTP values.</s><s xml:id="_k8R9C6f">Based on the cost-effectiveness ratio from the health care system perspective, there was an annual cost of US $71.00 and US $31.00 per 1-unit improvement in physical functioning and in pain, as measured by the Arthritis Impact Measurement Scales, respectively <ref type="bibr" target="#b26">[28]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_H2vmYM5">Chronic Pain</head><p xml:id="_Td37wx6"><s xml:id="_2JvfWzy">Three studies <ref type="bibr" target="#b19">[21,</ref><ref type="bibr" target="#b24">26,</ref><ref type="bibr" target="#b27">29]</ref> compared the cost-effectiveness of digital health intervention with usual care on people with chronic pain.</s><s xml:id="_T8bjxGC">The digital health interventions include therapist-supported treatment comprising about 100 pages divided into 8 modules of self-help material, cognitive-behavioral intervention with email contact of the therapist, and transdiagnostic psychological intervention delivered via the internet.</s><s xml:id="_JBYtAj4">The clinical outcomes were disability, health status (fibromyalgia), physical functioning, and pain.</s><s xml:id="_uK9bF77">All these studies reported that digital health interventions were cost-effective.</s><s xml:id="_uGRDXyF">For a unit reduction (≥30%) in disability, depression, anxiety, and pain, a self-guided internet-based intervention and control or clinician-guided intervention costs from Aus $404 (US $273.05) to Aus $808 (US $546.09) and Aus $88 (US $59.48) to Aus $225 (US $152.07),</s><s xml:id="_bpHrJc2">respectively <ref type="bibr" target="#b19">[21]</ref>.</s><s xml:id="_WJSCyy6">Taking the societal and health care perspectives, the cost-effectiveness ratio between the internet-delivered pain management group and the control group was US $15,295 and US $2211 for 1 additional responder to treatment, respectively <ref type="bibr" target="#b24">[26]</ref>.</s><s xml:id="_ud2fBha">Compared with control, the internet-based cognitive-behavioral intervention showed a saving of €40 (US $43.12) per additional point improvement gained on the Pain Catastrophizing Scale <ref type="bibr" target="#b27">[29]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_buwGmzy">Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XFcv9CK">Key Findings</head><p xml:id="_Q6n7nhm"><s xml:id="_eNUM2jS">To the best of our knowledge, this is the first study to perform a systematic review and meta-analysis on critically appraising the cost-effectiveness of digital health interventions for patients with MSDs.</s><s xml:id="_NStwVsZ">A total of 10 studies from 6 countries were included.</s><s xml:id="_ZsUhPDN">The results of our analysis show that there is strong evidence to support that digital health interventions are cost-effective.</s><s xml:id="_vUYS4ws">From a societal perspective, telephone-based weight loss support provided using an existing nondisease-specific 6-month weight management and healthy lifestyle service was not cost-effective in comparison to usual care for patients with osteoarthritis <ref type="bibr" target="#b25">[27]</ref>.</s><s xml:id="_JQYFkth">However, it should be noted that health service delivery systems are not the same in different countries.</s><s xml:id="_fXM8XSN">Moreover, cost-effectiveness results may differ from 1 region to another, as countries have differences in demography and epidemiology.</s></p><p xml:id="_SqcSRFP"><s xml:id="_WKkB9Jp">Nicholl and colleagues <ref type="bibr" target="#b29">[31]</ref> conducted a systematic review to critically appraise published evidence concerning the use of interactive digital health interventions to support self-management of LBP.</s><s xml:id="_GpYFGfA">These authors indicated that no information on cost-effectiveness was reported.</s><s xml:id="_zkvvxtB">However, a recently published review <ref type="bibr" target="#b11">[12]</ref> has demonstrated that digital health interventions have some clinical benefits in the management of MSDs and may contribute positively toward reducing its multifaceted burden to the individual, economy, and society.</s></p><p xml:id="_GaYuqFE"><s xml:id="_PZDN84r">A substantial difference exists in the applicability of digital health interventions in high-income as well as low-and middle-income countries <ref type="bibr" target="#b30">[32]</ref>.</s><s xml:id="_9tF4wJu">For example, telerehabilitation, in the form of a mobile phone app platform extension exercise, may be a practical intervention in geographically remote areas <ref type="bibr" target="#b21">[23]</ref>.</s><s xml:id="_92nyHqT">Consistent with our findings, taking a lifetime perspective, the use of a mobile app for the self-management of heart diseases by patients with heart failure (in a Spanish region) appeared cost-effective compared with usual care <ref type="bibr" target="#b31">[33]</ref>.</s><s xml:id="_gvuUArr">Although the type of digital health interventions is one of the influential cost drivers <ref type="bibr" target="#b32">[34]</ref>, it seems that they are cost-effective in both high-and low-income countries.</s></p><p xml:id="_r7MJ2h2"><s xml:id="_PFXr6BH">Some of the main reasons for the cost-effectiveness of digital health interventions are early identification of a disease using technology and savings made on direct nonmedical costs or indirect costs.</s><s xml:id="_xZ8pQmy">Further, prevention of disease progression and its costly health outcomes could be possible through early detection of a disease.</s><s xml:id="_4J6HZRg">For example, those conditions that have been promptly detected or identified could receive intervention or treatment to prevent its progress.</s><s xml:id="_5ps57vM">Furthermore, using digital health interventions may enable clinicians to reduce time spent for each patient, which in return reduces overall health care resources and in turn burden on the society.</s></p><p xml:id="_jHUQYqs"><s xml:id="_z89E2cF">A meta-analysis could not be performed for most of the included studies in this current review.</s><s xml:id="_s7N7fRW">This is because the included studies used different time horizons, different clinical outcomes, and did not present mean or SD for costs.</s><s xml:id="_km4zF8z">However, it was possible to pool effectiveness and cost data from 2 studies <ref type="bibr" target="#b22">[24,</ref><ref type="bibr" target="#b23">25]</ref>.</s><s xml:id="_KUEPbTf">From a societal perspective, compared with the control group, the meta-analysis results of these 2 studies suggest that the digital health intervention is more effective and less costly.</s><s xml:id="_SVA6fYj">This suggests that digital health interventions are cost-effective compared with control.</s><s xml:id="_NZ2Gt8m">Among other parameters, it is important to consider the transferability of the cost-effectiveness results from other countries before using them in the decision-making process.</s><s xml:id="_F9sY6Bn">Therefore, this review could provide useful information that digital health interventions are cost-effective and policy makers can apply regional cost-effectiveness data to their local decision-making.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fvtaw3X">Strengths and Limitations</head><p xml:id="_x5S2ZNa"><s xml:id="_JkYxjxt">There are certain strength and limitations to this study.</s><s xml:id="_Jc9YA7p">In this review, we used a systematic approach such as the screening of numerous databases, the involvement of multiple reviewers, and assessment of methodological quality of the studies.</s><s xml:id="_Bxmzn2Q">Only English language studies were included.</s><s xml:id="_m2nBer4">Therefore, it is possible that relevant literature published in other languages may have been excluded.</s><s xml:id="_WkYhsME">Only a small number of studies met the inclusion criteria.</s><s xml:id="_rTc55q8">It was also not possible to perform a meta-analysis for most of the included studies due to the adoption of different time horizons and different clinical outcomes; further, many studies did not present mean or SD for costs <ref type="bibr" target="#b33">[35]</ref>.</s><s xml:id="_RTHqr59">Besides, the quality of the included studies indicates that there is a need to interpret the cost-effectiveness results with caution.</s><s xml:id="_g5MNdgv">Finally, we found just 1 study precluding any meaningful conclusions on the cost-effectiveness of digital health interventions.</s><s xml:id="_tGdaDur">Overall, the findings of this review should be generalized only after taking local information such as perspective, time horizon, currency, and gross domestic product specific for each country into account <ref type="bibr" target="#b34">[36]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Ng9KvVg">Conclusions</head><p xml:id="_hCDUaes"><s xml:id="_jRErBGd">Studies indicate that digital health interventions are cost-effective.</s><s xml:id="_NkBetNM">Our findings also suggest that digital health interventions could help improve access to treatment for patients with MSDs, thereby improving their health outcomes.</s><s xml:id="_MUWy9Dz">Policy makers should consider the use of these interventions for patients with MSDs.</s><s xml:id="_JA4xmVY">This study may provide useful information to decision makers at a time when there is a shortage of economic evidence.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_FURbyTg"><s xml:id="_RncP4Kr">Figure 1.</s><s xml:id="_RSawSy7">Flow diagram of publications included and excluded in the review.</s></p></div></figDesc><graphic coords="3,56.69,449.09,481.86,274.66" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_FxGDGeR"><s xml:id="_dWrdY6E">Figure 2. Forest plots of comparison: digital health intervention vs control for low back pain.</s></p></div></figDesc><graphic coords="10,56.69,82.34,481.90,465.58" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_ew9FJMP"><s xml:id="_4SdyuRb">Characteristics of the included studies.</s></p></div></figDesc><table><row><cell cols="6">JOURNAL OF MEDICAL INTERNET RESEARCH</cell><cell></cell><cell></cell><cell></cell><cell>Fatoye et al</cell></row><row><cell>Author,</cell><cell>Sample size</cell><cell>Mean age</cell><cell>Follow-</cell><cell>Methods</cell><cell>Intervention modalities</cell><cell>Comparator</cell><cell>Perspec-</cell><cell>Reference costs</cell><cell>Interven-</cell></row><row><cell>country</cell><cell></cell><cell>(years)</cell><cell>up</cell><cell></cell><cell></cell><cell></cell><cell>tives</cell><cell></cell><cell>tion out-</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>comes</cell></row><row><cell>Suman et al [20], The</cell><cell>779 (n interven-tion =331 and n control =448)</cell><cell>Interven-tion group=55.7 (SD 13.9);</cell><cell>3 months</cell><cell>RCT a /CUA b</cell><cell>Access to a multifaceted eHealth strategy: informa-tive website, digital monthly newsletters, and</cell><cell>Digital patient information letter; no ac-cess to the</cell><cell>Societal</cell><cell>Intervention group=€8444 (US $10,000); control</cell><cell>Willing-ness to pay per quality-adjusted</cell></row><row><cell>Nether-</cell><cell></cell><cell>control</cell><cell></cell><cell></cell><cell>social media platforms</cell><cell>website, mate-</cell><cell></cell><cell>group=€8979</cell><cell>life-year</cell></row><row><cell>lands</cell><cell></cell><cell>group=56.6</cell><cell></cell><cell></cell><cell></cell><cell>rials, or social</cell><cell></cell><cell>(US</cell><cell></cell></row><row><cell></cell><cell></cell><cell>(SD 14.6)</cell><cell></cell><cell></cell><cell></cell><cell>media plat-</cell><cell></cell><cell>$10,632.52)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>forms</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Dear et al [21], Aus-tralia</cell><cell>490 (n interven-tion1 =143, n interven-tion2 =141, n interven-</cell><cell>50 (SD 13)</cell><cell>8 weeks</cell><cell>RCT/CEA c</cell><cell>Evidence-based face-to-face pain management programs; participants were also provided with information designed to help people understand</cell><cell>Usual care</cell><cell>Health care</cell><cell>N/A d</cell><cell>Cost per ≥30% re-duction in disability, depression, anxiety,</cell></row><row><cell></cell><cell>tion3 =131,</cell><cell></cell><cell></cell><cell></cell><cell>their symptoms and diffi-</cell><cell></cell><cell></cell><cell></cell><cell>and pain</cell></row><row><cell></cell><cell>and n con-</cell><cell></cell><cell></cell><cell></cell><cell>culties, and to teach cogni-</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>trol =75)</cell><cell></cell><cell></cell><cell></cell><cell>tive and behavioral self-</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>management skills to help</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>reduce pain-related disabil-</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>ity, anxiety, and depres-</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>sion.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Ekman</cell><cell>499 (75% fe-</cell><cell>65</cell><cell>12</cell><cell>Literature</cell><cell>It consists of a patient inter-</cell><cell>Face-to-face</cell><cell>Soci-</cell><cell>Societal costs:</cell><cell>Cost per</cell></row><row><cell>et al</cell><cell>male)</cell><cell></cell><cell>weeks</cell><cell>re-</cell><cell>face that provides individu-</cell><cell>treatment (two</cell><cell>etal/health</cell><cell>intervention</cell><cell>unit of ef-</cell></row><row><cell>[30],</cell><cell></cell><cell></cell><cell></cell><cell>view/CEA</cell><cell>ally tailored information</cell><cell>to three 1-</cell><cell>care</cell><cell>group=2776</cell><cell>fect im-</cell></row><row><cell>Sweden</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>on osteoarthritis and exer-</cell><cell>hour, physio-</cell><cell></cell><cell>SEK (US</cell><cell>provement</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>cises for rehabilitation and</cell><cell>therapist-led</cell><cell></cell><cell>$3234.8); con-</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>support for lifestyle</cell><cell>face-to-face</cell><cell></cell><cell>trol</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>changes. It includes a</cell><cell>lectures with</cell><cell></cell><cell>group=10,610</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>provider interface where a</cell><cell>information</cell><cell></cell><cell>SEK (US</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>trained physiotherapist can</cell><cell>about the con-</cell><cell></cell><cell>$12,363); health</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>follow progress of the pa-</cell><cell>dition and</cell><cell></cell><cell>care costs: inter-</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>tient and provide feedback</cell><cell>available treat-</cell><cell></cell><cell>vention</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and support throughout the</cell><cell>ment)</cell><cell></cell><cell>group=766 SEK</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>treatment period.</cell><cell></cell><cell></cell><cell>(US $892); con-</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>trol group=1299</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>SEK (US</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>$1513.7)</cell><cell></cell></row><row><cell>Fatoye</cell><cell>47 (n interven-</cell><cell>47 (SD</cell><cell>8 weeks</cell><cell>RCT/CEA</cell><cell>Telerehabilitation, a mo-</cell><cell>Usual care</cell><cell>Health</cell><cell>Intervention</cell><cell>Cost per</cell></row><row><cell>et al [23], Nigeria</cell><cell>tion =21 and n control =26)</cell><cell>11.6)</cell><cell></cell><cell>and CUA</cell><cell>bile phone-based app of mechanical diagnosis and therapy. Most of these</cell><cell></cell><cell>care</cell><cell>group=US $61.8; control group=US</cell><cell>quality-ad-justed life-year</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>participants were provided</cell><cell></cell><cell></cell><cell>$106.3</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>with smartphones.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Pagani-</cell><cell>302 (84.1%</cell><cell>51.7 (SD</cell><cell>6</cell><cell>RCT/CUA</cell><cell>A guided and unguided in-</cell><cell>Usual care and</cell><cell>Societal</cell><cell>Guided=€6945</cell><cell>Cost per</cell></row><row><cell>ni et al</cell><cell>female;</cell><cell>13.1)</cell><cell>months</cell><cell></cell><cell>ternet-based intervention.</cell><cell>participants</cell><cell></cell><cell>(US $8417.8);</cell><cell>quality-ad-</cell></row><row><cell>[24],</cell><cell>n=254)</cell><cell></cell><cell></cell><cell></cell><cell>It consists of 7 modules,</cell><cell>were offered</cell><cell></cell><cell>unguid-</cell><cell>justed life-</cell></row><row><cell>Ger-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>which include information,</cell><cell>to use the un-</cell><cell></cell><cell>ed=€6560 (US</cell><cell>year</cell></row><row><cell>many</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>metaphors, assignments,</cell><cell>guided inter-</cell><cell></cell><cell>$7951.1); con-</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>and mindfulness exercises.</cell><cell>net-based inter-</cell><cell></cell><cell>trol</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Participants were advised</cell><cell>vention after</cell><cell></cell><cell>group=€6908</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>to work on 1 module per</cell><cell>the last fol-</cell><cell></cell><cell>(US $8372.9)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>week (~60 minutes).</cell><cell>low-up assess-</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>ment</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Williams</cell><cell>160 (n interven-</cell><cell>Interven-</cell><cell>6</cell><cell>RCT/CEA</cell><cell>An intervention involving</cell><cell>Usual care (no</cell><cell>Societal</cell><cell>Intervention</cell><cell>Cost per</cell></row><row><cell>et al [25], Aus-</cell><cell>tion =79 and n control =80)</cell><cell>tion group=56.0 (SD 13.3);</cell><cell>months</cell><cell>and CUA</cell><cell>brief telephone advice, a clinical consultation with a physiotherapist, and refer-</cell><cell>restrictions were placed on their use of</cell><cell>and health care</cell><cell>group=Aus $1272 (US $1501.3); con-</cell><cell>quality-ad-justed life-year</cell></row><row><cell>tralia</cell><cell></cell><cell>control</cell><cell></cell><cell></cell><cell>ral to a 6-month telephone-</cell><cell>other health</cell><cell></cell><cell>trol group=Aus</cell><cell></cell></row><row><cell></cell><cell></cell><cell>group=57.4</cell><cell></cell><cell></cell><cell>based health coaching ser-</cell><cell>services dur-</cell><cell></cell><cell>$1886 (US</cell><cell></cell></row><row><cell></cell><cell></cell><cell>(SD 13.6)</cell><cell></cell><cell></cell><cell>vice</cell><cell>ing the study</cell><cell></cell><cell>$2225.9)</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>period)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>XSL • FO</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>RenderX</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_cDFh76Q"><p>b CUA: cost-utility analysis.</p><p>c CEA: cost-effectiveness analysis.</p><p><s xml:id="_qm5qdke">d N/A: not available.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_zcjWtnc"><s xml:id="_cRTFa9S">J Med Internet Res 2023 | vol. 25 | e41113 | p. 2 https://www.jmir.org/2023/1/e41113</s><s xml:id="_knCDd7n">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_38eKTkg"><s xml:id="_rE36ZSZ">J Med Internet Res 2023 | vol. 25 | e41113 | p. 3 https://www.jmir.org/2023/1/e41113</s><s xml:id="_UvHZJKy">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_eF8YUWF"><s xml:id="_a6Bntyt">J Med Internet Res 2023 | vol. 25 | e41113 | p. 4 https://www.jmir.org/2023/1/e41113</s><s xml:id="_CCJcVpZ">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_wMnsrPe"><s xml:id="_HxhMDEw">J Med Internet Res 2023 | vol. 25 | e41113 | p. 5 https://www.jmir.org/2023/1/e41113(page</s><s xml:id="_qZMM6hq">number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p xml:id="_8nmdwV9"><s xml:id="_T2sBzgY">J Med Internet Res 2023 | vol. 25 | e41113 | p. 6 https://www.jmir.org/2023/1/e41113</s><s xml:id="_nKpNja5">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_5"><p xml:id="_GBmArph"><s xml:id="_7fcnAGM">J Med Internet Res 2023 | vol. 25 | e41113 | p. 7 https://www.jmir.org/2023/1/e41113</s><s xml:id="_ArAa8Zp">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_6"><p xml:id="_W7YUjSU"><s xml:id="_rCrM5A5">J Med Internet Res 2023 | vol. 25 | e41113 | p. 8 https://www.jmir.org/2023/1/e41113</s><s xml:id="_q5Q9CXJ">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_7"><p xml:id="_phe6hy5"><s xml:id="_dqHzUny">J Med Internet Res 2023 | vol. 25 | e41113 | p. 9 https://www.jmir.org/2023/1/e41113</s><s xml:id="_AD7Cxch">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_8"><p xml:id="_RG22jYq"><s xml:id="_dRVWszT">J Med Internet Res 2023 | vol. 25 | e41113 | p. 10 https://www.jmir.org/2023/1/e41113</s><s xml:id="_738xsSZ">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_9"><p xml:id="_s7HbNN3"><s xml:id="_6ywwW5n">J Med Internet Res 2023 | vol. 25 | e41113 | p. 11 https://www.jmir.org/2023/1/e41113</s><s xml:id="_StPcXWh">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_10"><p xml:id="_fpRnNrR"><s xml:id="_UjejGJX">J Med Internet Res 2023 | vol. 25 | e41113 | p. 12 https://www.jmir.org/2023/1/e41113</s><s xml:id="_wb8qMdB">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_11"><p xml:id="_cHVC4u9"><s xml:id="_ACKU7Zb">J Med Internet Res 2023 | vol. 25 | e41113 | p. 13 https://www.jmir.org/2023/1/e41113</s><s xml:id="_YDE5MDS">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_12"><p xml:id="_A7ueMJz"><s xml:id="_y3yKAdd">J Med Internet Res 2023 | vol. 25 | e41113 | p. 14 https://www.jmir.org/2023/1/e41113</s><s xml:id="_uEsuxAb">(page number not for citation purposes)</s></p></note>
		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dwKeeSb">Data Sharing</head><p xml:id="_JJqau6p"><s xml:id="_pGpRR5A">All data related to this work are available in this research article..</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_brERvQq">Authors' Contributions</head><p xml:id="_dZCjeEm"><s xml:id="_cCsuNM2">FF, TG, CM, and UU have contributed equally to this paper.</s><s xml:id="_jUax7xK">All authors had conceived, designed, analyzed the data, and interpreted the results of the work.</s><s xml:id="_cB3kpE5">All authors approved the final version of this manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gtRYtav">Conflicts of Interest</head><p xml:id="_DDt9UFy"><s xml:id="_gDz8Au9">None declared.</s><s xml:id="_fPcSn69">©Francis Fatoye, Tadesse Gebrye, Chidozie Mbada, Ushotanefe Useh.</s><s xml:id="_9PaE45z">Originally published in the Journal of Medical Internet Research (<ref type="url" target="https://www.jmir.org">https://www.jmir.org</ref>),</s><s xml:id="_nHaudv2">06.07.2023.</s><s xml:id="_awdsaZs">This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ref type="url" target="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ref>),</s><s xml:id="_HrjuEC5">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited.</s><s xml:id="_pWvsZYX">The complete bibliographic information, a link to the original publication on <ref type="url" target="https://www.jmir.org/">https://www.jmir.org/</ref>,</s><s xml:id="_XugF3J3">as well as this copyright and license information must be included.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EhZY7wU">Multimedia Appendix 1</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_2p88v3x">Musculoskeletal disorders: OWAS review</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gómez-Galán</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pérez-Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Á</forename><forename type="middle">J</forename><surname>Callejón-Ferre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>López-Martínez</surname></persName>
		</author>
		<idno type="DOI">10.2486/indhealth.2016-0191</idno>
		<idno>Medline: 28484144</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nrWJUA7">Ind Health</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="314" to="337" />
			<date type="published" when="2017-08-08">2017 Aug 08</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Gómez-Galán M, Pérez-Alonso J, Callejón-Ferre ÁJ, López-Martínez J. Musculoskeletal disorders: OWAS review. Ind Health 2017 Aug 08;55(4):314-337 [FREE Full text] [doi: 10.2486/indhealth.2016-0191] [Medline: 28484144]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<idno type="DOI">10.1016/j.puhe.2007.03.012</idno>
		<ptr target="https://www.gov.uk/government/collections/musculoskeletal-diseases-profiles" />
		<title level="m" xml:id="_fVhh4Ja">PHE Fingertips Tool: Musculoskeletal Diseases Profile</title>
		<meeting><address><addrLine>London, UK</addrLine></address></meeting>
		<imprint>
			<publisher>Public Health England</publisher>
			<date type="published" when="2018">2018. 2021-09-26</date>
		</imprint>
	</monogr>
	<note type="raw_reference">PHE Fingertips Tool: Musculoskeletal Diseases Profile. Public Health England. London, UK: Public Health England; 2018. URL: https://www.gov.uk/government/collections/musculoskeletal-diseases-profiles [accessed 2021-09-26]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_nKkDRsX">Global, regional, and national burden of other musculoskeletal disorders 1990-2017: results from the Global Burden of Disease Study 2017</title>
		<author>
			<persName><forename type="first">S</forename><surname>Safiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kolahi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Carson-Chahhoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Almasi-Hashiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kaufman</surname></persName>
		</author>
		<idno type="DOI">10.1093/rheumatology/keaa315</idno>
		<idno>Medline: 32840303</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_92fAwKg">Rheumatology</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="855" to="865" />
			<date type="published" when="2021-02-01">2021 Feb 01</date>
			<pubPlace>Oxford</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Safiri S, Kolahi A, Cross M, Carson-Chahhoud K, Almasi-Hashiani A, Kaufman J, et al. Global, regional, and national burden of other musculoskeletal disorders 1990-2017: results from the Global Burden of Disease Study 2017. Rheumatology (Oxford) 2021 Feb 01;60(2):855-865 [doi: 10.1093/rheumatology/keaa315] [Medline: 32840303]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_JEJd5Mx">Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cieza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Causey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kamenov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Hanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chatterji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vos</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(20)32340-0</idno>
		<idno>Medline: 33275908</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_D3uw82z">Lancet</title>
		<imprint>
			<biblScope unit="volume">396</biblScope>
			<biblScope unit="issue">10267</biblScope>
			<biblScope unit="page" from="2006" to="2017" />
			<date type="published" when="2021-12-19">2021 Dec 19</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2021 Dec 19;396(10267):2006-2017 [doi: 10.1016/S0140-6736(20)32340-0] [Medline: 33275908]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<idno type="DOI">10.4309/jgi.2008.21.12</idno>
		<ptr target="http://www.boneandjointburden.org/docs/BMUSExecutiveSummary2016.pdf" />
		<title level="m" xml:id="_Hf92Y8H">The Impact of Musculoskeletal Disorders on Americans-Opportunities for Action</title>
		<imprint>
			<publisher>Bone and Joint Initiative USA</publisher>
			<date type="published" when="2016">2016. 2021-09-06</date>
		</imprint>
	</monogr>
	<note type="raw_reference">The Impact of Musculoskeletal Disorders on Americans-Opportunities for Action. Bone and Joint Initiative USA. 2016. URL: http://www.boneandjointburden.org/docs/BMUSExecutiveSummary2016.pdf [accessed 2021-09-06]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_xFu3Caf">Arthritis and other musculoskeletal conditions in numbers</title>
		<idno type="DOI">10.1002/msc.1393</idno>
		<ptr target="https://www.versusarthritis.org/media/14594/state-of-musculoskeletal-health-2019.pdf" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_gvGCQtb">Versus Arthritis</title>
		<imprint>
			<publisher>The State of Musculoskeletal Health</publisher>
			<date type="published" when="2019">2019. 2019. 2021-09-26</date>
		</imprint>
	</monogr>
	<note type="raw_reference">The State of Musculoskeletal Health 2019. Arthritis and other musculoskeletal conditions in numbers. Versus Arthritis. 2019. URL: https://www.versusarthritis.org/media/14594/state-of-musculoskeletal-health-2019.pdf [accessed 2021-09-26]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main" xml:id="_5CeaGM2">Rehabilitation 2030: A call for action</title>
		<idno type="DOI">10.23736/s1973-9087.17.04765-7</idno>
		<ptr target="https://www.who.int/publications/m/item/rehabilitation-2030-a-call-for-action" />
		<imprint>
			<date type="published" when="2017-02-07">2017 Feb 7. 2023-06-22</date>
			<publisher>WHO</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization (WHO). Rehabilitation 2030: A call for action. WHO. 2017 Feb 7. URL: https://www.who.int/ publications/m/item/rehabilitation-2030-a-call-for-action [accessed 2023-06-22]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_bnNYnZs">The effectiveness of mI SMART: A nurse practitioner led technology intervention for multiple chronic conditions in primary care</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mallow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Theeke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Theeke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Mallow</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijnss.2018.03.009</idno>
		<idno>Medline: 31406814</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xpzfJ6H">Int J Nurs Sci</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="131" to="137" />
			<date type="published" when="2018-04-10">2018 Apr 10</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Mallow JA, Theeke LA, Theeke E, Mallow BK. The effectiveness of mI SMART: A nurse practitioner led technology intervention for multiple chronic conditions in primary care. Int J Nurs Sci 2018 Apr 10;5(2):131-137 [FREE Full text] [doi: 10.1016/j.ijnss.2018.03.009] [Medline: 31406814]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_8v5WpG3">The medium, the message and the measure: a theory-driven review on the value of telehealth as a patient-facing digital health innovation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Abimbola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Keelan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Everett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Casburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Burchfield</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13561-019-0239-5</idno>
		<idno>Medline: 31270685</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rJrFzBw">Health Econ Rev</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">21</biblScope>
			<date type="published" when="2019-07-03">2019 Jul 03</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Abimbola S, Keelan S, Everett M, Casburn K, Mitchell M, Burchfield K, et al. The medium, the message and the measure: a theory-driven review on the value of telehealth as a patient-facing digital health innovation. Health Econ Rev 2019 Jul 03;9(1):21 [FREE Full text] [doi: 10.1186/s13561-019-0239-5] [Medline: 31270685]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_8Gj24dZ">Effectiveness of an Internet-Delivered Exercise and Pain-Coping Skills Training Intervention for Persons With Chronic Knee Pain: A Randomized Trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Bennell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nelligan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Keefe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kasza</surname></persName>
		</author>
		<idno type="DOI">10.7326/m16-1714</idno>
		<idno>Medline: 28241215</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EbqPA2Y">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="453" to="462" />
			<date type="published" when="2017-04-04">2017 Apr 04</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bennell KL, Nelligan R, Dobson F, Rini C, Keefe F, Kasza J, et al. Effectiveness of an Internet-Delivered Exercise and Pain-Coping Skills Training Intervention for Persons With Chronic Knee Pain: A Randomized Trial. Ann Intern Med 2017 Apr 04;166(7):453-462 [doi: 10.7326/M16-1714] [Medline: 28241215]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_SAwyf2T">Evaluating Digital Health Interventions: Key Questions and Approaches</title>
		<author>
			<persName><forename type="first">E</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Hekler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Doherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hollis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2016.06.008</idno>
		<idno>Medline: 27745684</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dFBpKET">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="843" to="851" />
			<date type="published" when="2016-11">2016 Nov</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Murray E, Hekler EB, Andersson G, Collins LM, Doherty A, Hollis C, et al. Evaluating Digital Health Interventions: Key Questions and Approaches. Am J Prev Med 2016 Nov;51(5):843-851 [FREE Full text] [doi: 10.1016/j.amepre.2016.06.008] [Medline: 27745684]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_mkNcwcH">The Effectiveness of Digital Health Interventions in the Management of Musculoskeletal Conditions: Systematic Literature Review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sephton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yeowell</surname></persName>
		</author>
		<idno type="DOI">10.2196/15617</idno>
		<idno>Medline: 32501277</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WD43SgN">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">15617</biblScope>
			<date type="published" when="2020-06-05">2020 Jun 05</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Hewitt S, Sephton R, Yeowell G. The Effectiveness of Digital Health Interventions in the Management of Musculoskeletal Conditions: Systematic Literature Review. J Med Internet Res 2020 Jun 05;22(6):e15617 [FREE Full text] [doi: 10.2196/15617] [Medline: 32501277]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_ehGvTM2">The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration</title>
		<author>
			<persName><forename type="first">A</forename><surname>Liberati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tetzlaff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mulrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Gøtzsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Ioannidis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2009.06.006</idno>
		<idno>Medline: 19631507</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Y4WDETm">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1" to="34" />
			<date type="published" when="2009-10">2009 Oct</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009 Oct;62(10):e1-34 [FREE Full text] [doi: 10.1016/j.jclinepi.2009.06.006] [Medline: 19631507]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_sYk4hY8">Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Mcqueen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Sheehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Whittington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jfm</forename><surname>Van Boven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Campbell</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40273-018-0658-x</idno>
		<idno>Medline: 29736895</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QfQzC6a">Pharmacoeconomics</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="957" to="971" />
			<date type="published" when="2018-08">2018 Aug</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McQueen RB, Sheehan DN, Whittington MD, van Boven JFM, Campbell JD. Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations. Pharmacoeconomics 2018 Aug;36(8):957-971 [doi: 10.1007/s40273-018-0658-x] [Medline: 29736895]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_kBYbbG6">A systematic review of scope and quality of health economic evaluation studies in Vietnam</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">X</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Nong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Maher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Luu</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0103825</idno>
		<idno>Medline: 25122180</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YjUs6Zb">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">103825</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Tran BX, Nong VM, Maher RM, Nguyen PK, Luu HN. A systematic review of scope and quality of health economic evaluation studies in Vietnam. PLoS One 2014;9(8):e103825 [FREE Full text] [doi: 10.1371/journal.pone.0103825] [Medline: 25122180]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_DPp5mpt">Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Treweek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lockhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pitkethly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kjeldstrøm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johansen</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2012-002360</idno>
		<idno>Medline: 23396504</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yeXP3rh">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">2360</biblScope>
			<date type="published" when="2013-02-07">2013 Feb 07</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Treweek S, Lockhart P, Pitkethly M, Cook JA, Kjeldstrøm M, Johansen M, et al. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open 2013 Feb 07;3(2):e002360 [FREE Full text] [doi: 10.1136/bmjopen-2012-002360] [Medline: 23396504]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title level="m" type="main" xml:id="_4jPM7Mc">Purchasing power parities</title>
		<idno type="DOI">10.1787/888932502353</idno>
		<ptr target="https://salaryconverter.nigelb.me/" />
		<imprint>
			<date type="published" when="2021-08-01">2021. 2021-08-01</date>
			<publisher>Salary Converter</publisher>
		</imprint>
		<respStmt>
			<orgName>Salary Convertor</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Salary Convertor. Purchasing power parities. Salary Converter. 2021. URL: https://salaryconverter.nigelb.me/ [accessed 2021-08-01]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_sVyYMj7">Mechanism of action of luteinizing hormone-releasing hormone</title>
		<author>
			<persName><forename type="first">F</forename><surname>Labrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pelletier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Borgeat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Drouin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Savary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coté</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-1-4684-2889-6_19</idno>
		<idno>Medline: 4374927</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Jd7hXcB">Basic Life Sci</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="289" to="305" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
	<note>PART A</note>
	<note type="raw_reference">Labrie F, Pelletier G, Borgeat P, Drouin J, Savary M, Coté J. Mechanism of action of luteinizing hormone-releasing hormone. Basic Life Sci 1974;4(PART A):289-305 [doi: 10.1007/978-1-4684-2889-6_19] [Medline: 4374927]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_zPksmKF">The clinical nurse specialist in oncology</title>
		<author>
			<persName><forename type="first">S</forename><surname>Siehl</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0029-6465(22)01693-0</idno>
		<idno>Medline: 6924789</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_guQUa8z">Nurs Clin North Am</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="753" to="761" />
			<date type="published" when="1982-12">1982 Dec</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Siehl S. The clinical nurse specialist in oncology. Nurs Clin North Am 1982 Dec;17(4):753-761 [Medline: 6924789]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_8bZPq8Z">A Cost-effectiveness Analysis of an Internet-delivered Pain Management Program Delivered With Different Levels of Clinician Support: Results From a Randomised Controlled Trial</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Dear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Karin</forename><forename type="middle">E</forename><surname>Fogliati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dudeney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nielssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.jpain.2020.11.003</idno>
		<idno>Medline: 33227510</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fRhreUX">J Pain</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="344" to="358" />
			<date type="published" when="2021-03">2021 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dear BF, Karin E, Fogliati R, Dudeney J, Nielssen O, Scott AJ, et al. A Cost-effectiveness Analysis of an Internet-delivered Pain Management Program Delivered With Different Levels of Clinician Support: Results From a Randomised Controlled Trial. J Pain 2021 Mar;22(3):344-358 [doi: 10.1016/j.jpain.2020.11.003] [Medline: 33227510]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_zUGgNJk">Web-Based Self-Directed Exercise Program Is Cost-Effective Compared to Formal Physical Therapy After Primary Total Knee Arthroplasty</title>
		<author>
			<persName><forename type="first">E</forename><surname>Zachwieja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Theosmy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Yacovelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Beatty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Mcgrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lonner</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.arth.2020.04.061</idno>
		<idno>Medline: 32423757</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_h53juH9">J Arthroplasty</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2335" to="2341" />
			<date type="published" when="2020-09">2020 Sep</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zachwieja E, Theosmy EG, Yacovelli SJ, Beatty EW, McGrath ME, Lonner JH. Web-Based Self-Directed Exercise Program Is Cost-Effective Compared to Formal Physical Therapy After Primary Total Knee Arthroplasty. J Arthroplasty 2020 Sep;35(9):2335-2341 [doi: 10.1016/j.arth.2020.04.061] [Medline: 32423757]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_6uEaaed">The Clinical and Cost-Effectiveness of Telerehabilitation for People With Nonspecific Chronic Low Back Pain: Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">F</forename><surname>Fatoye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gebrye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fatoye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Mbada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Olaoye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Odole</surname></persName>
		</author>
		<idno type="DOI">10.2196/15375</idno>
		<idno>Medline: 32357128</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wrAjv7c">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">15375</biblScope>
			<date type="published" when="2020-06-24">2020 Jun 24</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Fatoye F, Gebrye T, Fatoye C, Mbada CE, Olaoye MI, Odole AC, et al. The Clinical and Cost-Effectiveness of Telerehabilitation for People With Nonspecific Chronic Low Back Pain: Randomized Controlled Trial. JMIR Mhealth Uhealth 2020 Jun 24;8(6):e15375 [FREE Full text] [doi: 10.2196/15375] [Medline: 32357128]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_T9pFEBX">A guided and unguided internet-and mobile-based intervention for chronic pain: health economic evaluation alongside a randomised controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Paganini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kählke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Buntrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Leiding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Ebert</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2018-023390</idno>
		<idno>Medline: 30967405</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NhUEPx3">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">23390</biblScope>
			<date type="published" when="2019-04-09">2019 Apr 09</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Paganini S, Lin J, Kählke F, Buntrock C, Leiding D, Ebert DD, et al. A guided and unguided internet-and mobile-based intervention for chronic pain: health economic evaluation alongside a randomised controlled trial. BMJ Open 2019 Apr 09;9(4):e023390 [FREE Full text] [doi: 10.1136/bmjopen-2018-023390] [Medline: 30967405]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_Bh9f37s">Economic evaluation of a healthy lifestyle intervention for chronic low back pain: A randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Van Dongen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kamper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Wolfenden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yoong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename></persName>
		</author>
		<idno type="DOI">10.1002/ejp.1334</idno>
		<idno>Medline: 30379386</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EerzeVF">Eur J Pain</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="621" to="634" />
			<date type="published" when="2019-03">2019 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Williams A, van Dongen JM, Kamper SJ, O&apos;Brien KM, Wolfenden L, Yoong SL, et al. Economic evaluation of a healthy lifestyle intervention for chronic low back pain: A randomized controlled trial. Eur J Pain 2019 Mar;23(3):621-634 [doi: 10.1002/ejp.1334] [Medline: 30379386]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_tqNAQ99">Internet-Delivered Exposure Therapy for Fibromyalgia: A Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hedman-Lagerlöf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hedman-Lagerlöf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Axelsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ljótsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Engelbrektsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hultkrantz</surname></persName>
		</author>
		<idno type="DOI">10.1097/ajp.0000000000000566</idno>
		<idno>Medline: 29077623</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PyWBbk8">Clin J Pain</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="532" to="542" />
			<date type="published" when="2018-06">2018 Jun</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hedman-Lagerlöf M, Hedman-Lagerlöf E, Axelsson E, Ljótsson B, Engelbrektsson J, Hultkrantz S, et al. Internet-Delivered Exposure Therapy for Fibromyalgia: A Randomized Controlled Trial. Clin J Pain 2018 Jun;34(6):532-542 [doi: 10.1097/AJP.0000000000000566] [Medline: 29077623]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_RGxwzxk">Economic evaluation of telephone-based weight loss support for patients with knee osteoarthritis: a randomised controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Van Dongen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kamper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wiggers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Hodder</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12889-018-6300-1</idno>
		<idno>Medline: 30587191</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_T79k9sE">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">1408</biblScope>
			<date type="published" when="2018-12-27">2018 Dec 27</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">O&apos;Brien KM, van Dongen JM, Williams A, Kamper SJ, Wiggers J, Hodder RK, et al. Economic evaluation of telephone-based weight loss support for patients with knee osteoarthritis: a randomised controlled trial. BMC Public Health 2018 Dec 27;18(1):1408 [FREE Full text] [doi: 10.1186/s12889-018-6300-1] [Medline: 30587191]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_Q4KKRHq">Cost-effectiveness of increased telephone contact for patients with osteoarthritis. A randomized, controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Weinberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Tierney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Cowper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Booher</surname></persName>
		</author>
		<idno type="DOI">10.1002/art.1780360216</idno>
		<idno>Medline: 7679273</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MXPykQA">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="243" to="246" />
			<date type="published" when="1993-02">1993 Feb</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weinberger M, Tierney WM, Cowper PA, Katz BP, Booher PA. Cost-effectiveness of increased telephone contact for patients with osteoarthritis. A randomized, controlled trial. Arthritis Rheum 1993 Feb;36(2):243-246 [doi: 10.1002/art.1780360216] [Medline: 7679273]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_8MHJmcj">A randomized controlled trial of an Internet-based cognitive-behavioural intervention for non-specific chronic pain: an effectiveness and cost-effectiveness study</title>
		<author>
			<persName><forename type="first">M</forename><surname>De Boer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Versteegen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Vermeulen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sanderman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Struys</surname></persName>
		</author>
		<idno type="DOI">10.1002/ejp.509</idno>
		<idno>Medline: 24777973</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9rqY7v6">Eur J Pain</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1440" to="1451" />
			<date type="published" when="2014-11">2014 Nov</date>
		</imprint>
	</monogr>
	<note type="raw_reference">de Boer M, Versteegen G, Vermeulen K, Sanderman R, Struys M. A randomized controlled trial of an Internet-based cognitive-behavioural intervention for non-specific chronic pain: an effectiveness and cost-effectiveness study. Eur J Pain 2014 Nov;18(10):1440-1451 [doi: 10.1002/ejp.509] [Medline: 24777973]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_Y9wjtPP">Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ekman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Lohmander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Dahlberg</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0236342</idno>
		<idno>Medline: 32785226</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mkUK3vk">PLoS One</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">236342</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Ekman B, Nero H, Lohmander LS, Dahlberg LE. Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden. PLoS One 2020;15(8):e0236342 [FREE Full text] [doi: 10.1371/journal.pone.0236342] [Medline: 32785226]</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_NWCGSkJ">Digital Support Interventions for the Self-Management of Low Back Pain: A Systematic Review</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">I</forename><surname>Nicholl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Sandal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Stochkendahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mccallum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Suresh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Vasseljen</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.7290</idno>
		<idno>Medline: 28550009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UsxwgZk">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e179</biblScope>
			<date type="published" when="2017-05-21">2017 May 21</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Nicholl BI, Sandal LF, Stochkendahl MJ, McCallum M, Suresh N, Vasseljen O, et al. Digital Support Interventions for the Self-Management of Low Back Pain: A Systematic Review. J Med Internet Res 2017 May 21;19(5):e179 [FREE Full text] [doi: 10.2196/jmir.7290] [Medline: 28550009]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_JfyUnGt">Best practices in scaling digital health in low and middle income countries</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Labrique</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wadhwani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lamptey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hesp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Luk</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12992-018-0424-z</idno>
		<idno>Medline: 30390686</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_86zck7K">Global Health</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">103</biblScope>
			<date type="published" when="2018-11-03">2018 Nov 03</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Labrique AB, Wadhwani C, Williams KA, Lamptey P, Hesp C, Luk R, et al. Best practices in scaling digital health in low and middle income countries. Global Health 2018 Nov 03;14(1):103 [FREE Full text] [doi: 10.1186/s12992-018-0424-z] [Medline: 30390686]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_QFhrkdE">Economic impact assessment from the use of a mobile app for the self-management of heart diseases by patients with heart failure in a Spanish region</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cano Martín</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Martínez-Pérez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>De La Torre-Díez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">López-</forename><surname>Coronado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1007/s10916-014-0096-z</idno>
		<idno>Medline: 24994514</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_C8DgQ78">J Med Syst</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">96</biblScope>
			<date type="published" when="2014-09-04">2014 Sep 4</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cano Martín JA, Martínez-Pérez B, de la Torre-Díez I, López-Coronado M. Economic impact assessment from the use of a mobile app for the self-management of heart diseases by patients with heart failure in a Spanish region. J Med Syst 2014 Sep 4;38(9):96 [doi: 10.1007/s10916-014-0096-z] [Medline: 24994514]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_D6hdQuA">The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review</title>
		<author>
			<persName><forename type="first">X</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ming</forename><forename type="middle">W</forename><surname>You</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename></persName>
		</author>
		<idno type="DOI">10.2196/13166</idno>
		<idno>Medline: 31210136</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_swcppwu">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">13166</biblScope>
			<date type="published" when="2019-06-17">2019 Jun 17</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jiang X, Ming W, You JH. The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review. J Med Internet Res 2019 Jun 17;21(6):e13166 [doi: 10.2196/13166] [Medline: 31210136]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title level="m" type="main" xml:id="_3RQtwH7">Cochrane Handbook for Systematic Reviews of Interventions Version 5</title>
		<author>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Green</surname></persName>
		</author>
		<idno type="DOI">10.1002/9780470712184</idno>
		<imprint>
			<date type="published" when="2010">2010</date>
			<publisher>John Wiley &amp; Sons</publisher>
			<pubPlace>Chichester, UK</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Chichester, UK: John Wiley &amp; Sons; 2010.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<author>
			<persName><forename type="first">A</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wolstenholme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wordsworth</surname></persName>
		</author>
		<title level="m" xml:id="_5ZKjSKT">Applied Methods of Cost-effectiveness Analysis in Healthcare</title>
		<meeting><address><addrLine>Oxford, UK</addrLine></address></meeting>
		<imprint>
			<publisher>Oxford University Press</publisher>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gray A, Clarke P, Wolstenholme J, Wordsworth S. Applied Methods of Cost-effectiveness Analysis in Healthcare. Oxford, UK: Oxford University Press; 2011.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
